
Publikationen von Christopher E. Martin
Alle Typen
Zeitschriftenartikel (13)
2019
Zeitschriftenartikel
14 (12), S. 2720 - 2728 (2019)
Synthetic oligosaccharide-based vaccines protect mice from clostridioides difficile infections. ACS Chemical Biology
Zeitschriftenartikel
116 (6), S. 1958 - 1967 (2019)
Microbe-focused glycan array screening platform. Proceedings of the National Academy of Sciences of the United States of America 2017
Zeitschriftenartikel
114 (42), S. 11063 - 11068 (2017)
Semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5. Proceedings of the National Academy of Sciences of the United States of America 2016
Zeitschriftenartikel
23 (8), S. 1014 - 1022 (2016)
Synthetic lipoteichoic acid glycans are potential vaccine candidates to protect from Clostridium difficile infections. Cell Chemical Biology
Zeitschriftenartikel
7, 11224 (2016)
Multivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycans. Nature Communications
Zeitschriftenartikel
6, 20488 (2016)
Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites. Scientific Reports 2015
Zeitschriftenartikel
16 (7), S. 2188 - 2197 (2015)
A self-assembling peptide scaffold for the multivalent presentation of antigens. Biomacromolecules 2013
Zeitschriftenartikel
8 (11), S. 2412 - 2422 (2013)
Immunogenicity and diagnostic potential of synthetic antigenic cell surface glycans of Leishmania. ACS Chemical Biology
Zeitschriftenartikel
49 (64), S. 7159 - 7161 (2013)
Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine. Chemical Communications
Zeitschriftenartikel
135 (26), S. 9713 - 9722 (2013)
Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitope. Journal of the American Chemical Society
Zeitschriftenartikel
135 (16), S. 6262 - 6271 (2013)
Diversity-oriented synthesis of inner core oligosaccharides of the lipopolysaccharide of pathogenic Gram-negative bacteria. Journal of the American Chemical Society 2012
Zeitschriftenartikel
3 (3), S. 896 - 899 (2012)
Total synthesis of the core tetrasaccharide of Neisseria meningitidis lipopolysaccharide, a potential vaccine candidate for meningococcal diseases. Chemical Science 2011
Zeitschriftenartikel
47 (37), S. 10260 - 10262 (2011)
Progress toward developing a carbohydrate-conjugate vaccine against Clostridium difficile ribotype 027: synthesis of the cell-surface polysaccharide PS-I repeating unit. Chemical Communications Meeting Abstract (1)
2014
Meeting Abstract
24 (11), S. 1129 - 1129. Joint Meeting of the Society-for-Glycobiology (SFG) and the
Japanese-Society-of-Carbohydrate-Research (JSCR), Honolulu, HI, 16. November 2014 - 19. November 2014. Oxford University Press, Oxford (2014)
Deciphering glycan-antibody interactions: towards a carbohydrate-based vaccine against Clostridium difficile. In Glycobiology, Hochschulschrift - Doktorarbeit (1)
2014
Hochschulschrift - Doktorarbeit
Chemical synthesis and biological evaluation of cell surface carbohydrate antigens for rational vaccine design. Dissertation, Freie Universität Berlin, Berlin (2014)
Patent (3)
2016
Patent
Vaccines against Streptococcus pneumoniae serotype 5. WO2016198170 (2016)
Patent
Antibodies for prevention and treatment of diseases caused by Clostridium difficile. (2016)
2013
Patent
Oligosaccharides and oligosaccharides-protein conjugates derived from clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools. EP2739636 (2013)